Site Search
433 Results (showing 1 - 25)
Transgenomic Signs Deal to Sell Genetic Assay and Platforms Business
Adstec will assume the business, financial, and human resource commitments of the business and pay Transgenomic $300,000 for stock and inventory related to the business.
This Week in Nucleic Acids Research: Sep 30, 2015
In Nucleic Acids Research this week: literature-mining method for uncovering additional gene-disease associations, database of human embryonic stem cell and induced pluripotent stem cell lines, and more.
Can Have Them Both
PHG Foundation's Ron Zimmern and the CDC's Muin Khoury say a "multifaceted approach" is needed to address population health.
As president and CEO of the Rady Pediatric Genomics and Systems Medicine Institute, Kingsmore will be working toward adopting genomics to transform pediatric care.
A method developed at MIT creates polyacrylamide beads around droplets containing single cells to sequester bacterial genomes and allow for harsh lysis conditions; it then uses concatenated PCR and sequencing to address links between phylogeny and function.
Licenses Revoked
An informatician restricts the use of his phylogenetic tree-building tool to protest friendly immigration policies.
Leerink Initiates Coverage of Danaher With Outperform Rating
The investment bank was bullish on Danaher's impending split into two firms, opportunities for M&A, and the Beckman Coulter and Sciex businesses.
Malaria GWAS Uncovers Protective Locus
A chromosome 4 locus near glycophorin-coding genes appears to decrease the risk of severe malaria in African children, particularly those from East Africa.
The findings reveal a new layer of complexity around the role of microRNAs and highlight how race can influence their role in cancer and potentially other diseases.
Jefferies Downgrades Sequenom to Hold Following Firm's Investor Day
Jefferies said the investor day event did not provide insight into Sequenom's growth strategy in the increasingly competitive NIPT market.
Color Genomics hopes its recently launched benefits program will enable a broader population to have access to breast and ovarian cancer risk testing.
Cowen Initiates Coverage of NanoString
The investment bank gave shares of the molecular diagnostics firm an Outperform rating and a price target of $20 per share.
Longitudinal Child Study Uncovers Early Gut Microbes With Apparent Asthma Protective Effect
Four bacterial genera are found at lower levels in the gut microbiomes of three-month-old infants believed to be at risk of developing asthma later in life.
Agilent Names CBC Certified Service Provider for MiRNA Profiling
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
Physician-Investigators Win $5.8M in NIH Funds to Detect Bacterial Infection in Febrile Infants
Premium
The team has been monitoring changes in host gene expression patterns due to different types of infections, and hopes to develop a diagnostic test.
Thermo Fisher Completes Acquisition of Alfa Aesar
The UK firm provides chemicals for DNA-, RNA-, and PCR-based research, products for DNA and protein labeling, and proteomics reagents and kits.
Rosetta Inks Thyroid Cancer Testing Services Deal with FNApath
Under the arrangement, Rosetta would offer physicians the option to have thyroid samples analyzed by FNApath, with indeterminate samples tested with its microRNA assay.
Study Finds MicroRNA Signature That May Reflect Progression to Myeloma
NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.
Genomics England Taps Congenica, Omicia to Handle UK 100K Genomes Interpretation
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
The researchers increased the test's sensitivity for nucleotide variants from less than 96 percent to 99.5 percent and reduced the time to provisional results from 50 hours to 26 hours.
Congenica Receives £300K Innovate UK Grant
Congenica will use the grant to extend the functionality of Sapientia, its software for analyzing and interpreting whole-genome data.
Lauer for Extramural Research Post
Cardiologist Michael Lauer is to be the new deputy director of extramural research at the National Institutes of Health.
Veritas Genetics Partners With PGP to Offer $1K Genome
Veritas and the PGP share many of the same leaders, including Veritas Co-founder George Church, CSO Preston Estep, and CMO Joseph Thakuria.
New Institutions Gain Access to Sophia Genetics Technology
The 11 European organizations will use Sophia's technologies to provide genetic testing to their patients.